The fusion peptide encoded by the KANSL1::ARL17A fusion transcript lacks some functional domains, and therefore, cancer patients expressing KANSL1::ARL17A display reduced activities of the histone acetyltransferase KAT8 and p53 [32–34]. The gene discussed is KANSL1; the disease is cancer.